I’d like to share a final communication with investor relations after my revelation that LP is doing everything in her power to guarantee approval and bring DcVax-L to market (even if at the time expense of shareholders and patients):
On Fri, Feb 19, 2021 at 7:44 AM Dave Innes <Dinnes@nwbio.com> wrote:
10B,
I am always happy to answer legitimate questions when able . Unfortunately some questions, while legit cannot/should not be answered due to certain restraints we have . ( when is TLD for example ). Some take that as avoidance and others understand. We have more than 16000 investors and the job of satisfying all questions can be trying at times.
I appreciate your apologies, and please know I recognize that this has been a painful journey to many and we are working as hard as we can.
Please also understand,I don’t take anything personally and certainly never harbor any ill feelings or grudges. I have done this for over three decades on both sides and certainly understand the process and the frustration
Working hard to get this over the line.
Best
Dave
Sent from my iPhone
> On Feb 19, 2021, 10BAGGERZ wrote:
>
> ?Dave,
>
> I took a long hard think about whether I believe that LP is doing everything in her power to bring a treatment to market. Based on everything that has transpired over the past 6 months I truly believe she is. As such, I now realize that the pre-TLD share price does not matter.
>
> I’d like to apologize (especially on a down day) for venting previous frustrations in your direction. I do appreciate all the extra time and information you’ve given me. I will not be emailing you again unless I feel I have a legitimate question that you might be able to answer.
>
> Best, 10B
